Madonella Mite

Ethinylestradiol and Levonorgestrel, the active ingredients in Madonella Mite, are a combined estrogen‑progestogen oral contraceptive presented as a tablet for oral use. It prevents pregnancy by inhibiting ovulation and altering cervical mucus in women of reproductive age.

GNH USA supplies Madonella Mite as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution through established logistics networks.

Madonella Mite, a combined estrogen‑progestogen oral contraceptive, is indicated for the following clinical uses:

Contraception: Prevents pregnancy in women of childbearing potential. Menstrual cycle regulation: Provides regular cycles and reduces dysmenorrhea. Acne treatment: Improves moderate acne linked to hormonal fluctuations. Premenstrual syndrome relief: Alleviates PMS symptoms such as bloating and mood swings. Endometriosis management: Reduces pain associated with endometriosis.

Madonella Mite may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Nausea - Headache - Breast tenderness - Spotting or breakthrough bleeding - Weight gain - Mood changes

Serious or Rare Side Effects: - Deep vein thrombosis - Pulmonary embolism - Stroke - Myocardial infarction - Severe hypertension - Hepatic adenoma or other liver tumors

Before prescribing Madonella Mite, clinicians should consider the following precautions:

Avoid use in pregnancy: product is contraindicated (Category X). Avoid use in active or past thromboembolic disease: increased clot risk. Avoid smoking in women over 35 years: heightened cardiovascular risk. Monitor blood pressure regularly: oral contraceptives may elevate BP. Assess liver function: contraindicated in severe hepatic impairment. Store at ambient temperature: keep below 25°C, protect from moisture and light.

Madonella Mite can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): reduced contraceptive effect. - Rifampin or rifabutin: decreased hormone levels, risk of pregnancy. - Protease inhibitors (e.g., ritonavir): may lower effectiveness.

Moderate Interactions (Monitor Closely): - St. John’s wort: may diminish contraceptive efficacy. - Certain antihypertensives: oral contraceptives can reduce BP control. - Selective serotonin reuptake inhibitors: may increase mood‑related side effects.